Creator of Diabetes Health Magazine, Scott King, has been a type 1 diabetic for over 34 years. Needless to say, he knows diabetes, and he is doing a remarkable job of introducing cutting-edge treatments for diabetics. In the first Diabetes Health TV broadcast, he shared interviews from the recent AADE Conference. A really exciting product he featured is called Neuragen - a topical treatment for diabetes neuropathy.

With diabetes neuropathy, people experience pain due to damage to the peripheral nerves. Neuropathic pain is often characterized by burning sensations or shooting pain, or may occur as numbness or chronic itching. Clinical trials have shown Neuragen to be effective in 70% of patients for the pain associated with diabetes. The ingredients are pretty kosher, too. Neuragen is made of a proprietary blend of essential oils from special species of geranium, lavender, bergamot, eucalyptus, and tea tree.

The Neuragen rep was blunt when he described the effective nature of this all natural product - using more does not make it any more effective! You have to admire his refreshing honesty. But like I said upfront - if Scott King is willing to spend the time getting the scoop on this product - it's probably worth your time using it. For more interviews, checkot the full coverage of the AADE Conference on Diabetes Health TV!

The New York Times is running a feature on the link between Type 2 diabetes and Alzheimer's disease. It basically sums up all the mounting evidence that there is a connection between the two diseases and explains why this connection may exist. The basis of the article is the presentation yesterday of new findings on the subject at a Madrid conference on Alzheimer's.

In a nutshell, here's what's known at this point: people with Type 2 diabetes are twice as likely to develop Alzheimer's disease. Researchers think maybe cardio problems related to having diabetes might inhibit blood flow to the brain, thereby contributing to dementia. More recently, researchers have found that both diabetes and Alzheimer's sufferers have a buildup of a certain protein in their bodies, giving rise to suspicions that the two diseases are somehow related in other ways. Some have even speculated that Alzheimer's might in fact be a type of diabetes - one that affects the nervous system.

Bottom line? It's a concern because it means that soaring rates of diabetes in the US will also mean a corresponding increase in Alzheimer's. Worst case scenario: "Alzheimer's is going to swamp the health care system" says Dr. John C. Morris, a professor at Washington University, in St. Louis, MO.

The article also touches on the possibility that diabetes control and prevention measures could, in theory, lower the risk of dementia also. I guess that's the silver lining to this cloud.